Company Filing History:
1 out of 43 
1 out of 2 Years Active: 2005-2006
Title: Marion J Bussemakers: Innovator in Prostate Cancer Research
Introduction
Marion J Bussemakers is a prominent inventor based in Nijmegen, Netherlands. She has made significant contributions to the field of prostate cancer research, particularly through her innovative work on nucleic acid molecules.
Latest Patents
Bussemakers holds 2 patents, with her latest invention focusing on nucleic acid molecules that comprise the promoter for the PCA3 gene. This invention describes the cloning and characterization of the promoter region for the PCA3 gene, which regulates PCA3 gene expression through a unique prostate-specific transcriptional mechanism. The invention also relates to the use of this promoter region as a tool for prostate cancer treatment, diagnosis, and screening of agents that regulate PCA3 expression. In a particular embodiment, the invention includes an isolated promoter sequence that enables prostate-specific modulation of transcription.
Career Highlights
Throughout her career, Bussemakers has worked with notable institutions, including the Catholic University of Nijmegen and the University Medical Centre Nijmegen. Her research has significantly advanced the understanding of prostate cancer and its treatment options.
Collaborations
Some of her notable coworkers include Gerald Verhaegh and Jack A Schalken, who have collaborated with her on various research projects.
Conclusion
Marion J Bussemakers is a key figure in the field of prostate cancer research, with her innovative patents paving the way for advancements in treatment and diagnosis. Her contributions continue to impact the medical community positively.